Summary
Overview
Work History
Education
Skills
Accomplishments
Timeline
Sukanya  Preedeewong

Sukanya Preedeewong

Pharmacist/Business Unit Director
Bangkok,Bangkok

Summary

As a proven business leader with 6 years of experience heading a specialty business unit in the pharmaceutical industry, I have consistently delivered exceptional growth, market leadership, and successful product launches across high-value therapeutic areas including Hematology, Rheumatology, Dermatology, Ophthalmology, Oncology, Urology, and Gastroenterology. Managing a USD 12M portfolio and leading a high-performing team of 25, I have driven strategic initiatives that strengthened our market position, expanded our product footprint, and maximized revenue across both direct and partner channels.

Overview

24
24
years of professional experience

Work History

Head of Oncology and Biosimilar

Sandoz Novartis (Thailand) LTD,
10.2021 - Current
  • Performed to lead Biosimilar Team to be Number 1 portfolio in Thailand and Succeed to present RIXATHON to be Number 1 in Private Channel and drive Hyrimoz to be Number 1 in Thailand both Government and Private Channel within 1 Year
  • Re Structure Oncology team by setting goal to be partnership with HCPs and enhance sale team member to focusing on scientific messages
  • Launched Project “Cluster Together “to collaboration between Biosimilar and Oncology team to exchange their competency
  • Established Digital Mindset to Team Member and get Awards from Commercial excellence team
  • Learned new skills and applied to daily tasks to improve efficiency and productivity
  • Monitored company inventory to keep stock levels and databases updated.

Business Manager Biosimilar Portfolio

Sandoz Novartis (Thailand) LTD,
07.2019 - 09.2021
  • Collaborating between company division to synergist quality of product
  • Deep drive to understanding Biosimilar Market positioning by to be partnering with specialty society
  • Be partnering with NLEM committees and CGD authorities to penetrate Biosimilar product to Thailand Healthcare System
  • Differentiated market target of Sandoz Biosimilar and Empower team members to deliver message to HCP
  • Initiated digital contents and activities to maximize sales and awareness
  • Collaborating with regional team to launch new products and set up strategy, execution plan included P&L
  • Support BD and L, portfolio by created forecast model input opportunity and assumption
  • Lead Biosimilar team by strengthen their capability
  • Driven sales and marketing team to expand opportunities for achieving budget
  • Actively listened to customers' requests, confirming full understanding before addressing concerns.
  • Developed team communications and information for meetings.

Product Manager and BD Project Manager

Mundipharma (Thailand ) LTD,
07.2018 - 06.2019
  • Identify opportunities and raises through proper channels
  • Managing complex business portfolio, and multiple business priorities
  • Managing challenging customer environment
  • Develop and maintain local customers and discover project opportunities
  • New products launch plan, preparation, execution and continuous follow up
  • Works collaboratively across SEA organization, such as vertical marketing
  • Forecast business size monthly, and execute appropriate action plan by detailed market mapping, competitive intelligence and future trend
  • Creating template to monitoring and analyzing business performance, market situation and competitors
  • Documented user stories, specifications and product features into detailed work order to communicate across teams and build mandatory requirements
  • Established criteria for each milestone within product roadmap as means to measure developmental progress

Production Manager

Boehringer Ingelheim(Thailand ) LTD,
07.2017 - 06.2018
  • Remake product strategy & product knowledge and selling skill
  • Training sales team and development of training materials
  • Creating local digital marketing
  • Creating “ Giotrif 10 reason campaign “ to differentiate from competitor
  • Launching oncology brand guidance to stakeholder to be “ one team “
  • Creating “ Irreversible project” to sale team to engage key user with sustainable
  • Creating marketing event “ Lux Lung Love “ to maximizing clinical trial to real word practice
  • Co-operation with multidisciplinary team for top 3 hospitals to create ‘’AE management guidance “
  • Slide pack to differentiate from competitor which easy to communication
  • Developing critical success factor with regional team
  • Resolved issues quickly to maintain productivity goals

Product Manager

Roche (Thailand ) LTD,
07.2015 - 06.2017
  • Training sales team and development of training materials
  • Creating patient’s assessment program both of ACTEMRA and Mabthera for patients who can no reimburse from CSMBS.
  • Convinced authorizers to believe in benefit of ACTEMRA and they allowed ACTEMRA reimbursing in CSMBS for RDPA registration program and UC funding for pediatrics.
  • Creating synergistic model for Rheumatology franchise ( Company of choice for rheumatology disease: ACTEMRA and Mabthera Cooperation project )
  • Launch cycle guide for territory manager to align new campaign.
  • Initiate Q and A handout for territory manager to manage objections by physicians.
  • Mabthera is Market leader of Rheumatology market and consistent growth
  • ACTEMRA sharing 11 % growth 14% even use in private segment
  • Reviewed new opportunities to drive business strategy at planning sessions

Senior Territory Manager

Roche (Thailand) LTD,
01.2007 - 06.2015
  • Responsible for Hematology area and promoted Mabthera NHL in Northern area.

Medical Representative

AstraZeneca (Thailand ) LTD,
01.2002 - 12.2006
  • Responsible for Respiratory area and promoted Symbicort in Bangkok area
  • Responsible for Cardiovascular area and promoted Crestor in Bangkok area
  • Responsible for Infectious area and promoted Meronem in Northern area

Education

MBA -

CHIANGMAI UNIVERSITY, THAILAND
2015

Ph.D. -

CHIANGMAI UNIVERSITY, THAILAND
2002

Skills

  • Team building
  • Decision-Making
  • Flexible and Adaptable
  • Active Listening
  • Fast to Resilience
  • Focus

Accomplishments

KEY ACHIEVEMENTS

Biosimilar Leadership – Spearheaded growth in biosimilar portfolio (Rituximab, Etanercept, Adalimumab) with sustained double- and triple-digit growth:

• 2019–2020: +2,569% | 2020–2021: +204% | 2021–2022: +52% | 2022–2023: +30% | 2023–2024: +22%.

• As of Mar 2025: Rank #1 with 41% market share, +27.6% growth vs. market’s +47.6%, ROS 51%.

Oncology Expansion – Strengthened oncology business with consistent growth, culminating in a 40% surge in 2023–2024 and market leadership in Fulvestrant (MKS 67%, +46% growth; ROS 55%).

High-Impact Launches – Successfully launched and scaled multiple key brands, achieving rapid market penetration:

• Rixathon (2019) – #3 at launch, now Rank #2 MKS.

• Erelzi (2020) – #2 MKS.

• Hyrimoz (2021) – Achieved #1 MKS with strong YoY growth.

• Fulvestrant (2021) – MKS 67% with sustained growth.

• Abiraterone (2024) – MKS 21%.

• Sorafenib (2025) – Launched in early 2025.

CORE COMPETENCIES

Team Leadership • P&L Management • Market Access Strategy • Product Launch Excellence • Cross-functional Collaboration • Revenue Growth Optimization

Timeline

Head of Oncology and Biosimilar - Sandoz Novartis (Thailand) LTD,
10.2021 - Current
Business Manager Biosimilar Portfolio - Sandoz Novartis (Thailand) LTD,
07.2019 - 09.2021
Product Manager and BD Project Manager - Mundipharma (Thailand ) LTD,
07.2018 - 06.2019
Production Manager - Boehringer Ingelheim(Thailand ) LTD,
07.2017 - 06.2018
Product Manager - Roche (Thailand ) LTD,
07.2015 - 06.2017
Senior Territory Manager - Roche (Thailand) LTD,
01.2007 - 06.2015
Medical Representative - AstraZeneca (Thailand ) LTD,
01.2002 - 12.2006
CHIANGMAI UNIVERSITY - MBA,
CHIANGMAI UNIVERSITY - Ph.D.,
Sukanya PreedeewongPharmacist/Business Unit Director